Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight

ClinicalTrials.gov ID: NCT06962280

Public ClinicalTrials.gov record NCT06962280. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 6:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Long-Term Safety of Tirzepatide Once Weekly Compared to Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to find out how well and how safely tirzepatide works long-term in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 20 months.

Study identification

NCT ID
NCT06962280
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
465 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 12, 2025 (Actual)
Primary completion
Nov 2026 (Estimated)
Completion
Jul 2027 (Estimated)
Last update posted
Feb 17, 2026

2025 – 2027

United States locations

U.S. sites
18
U.S. states
9
U.S. cities
18
Facility City State ZIP Site status
Kaiser Permanente Bonita Medical Offices Bonita California 91902 —
AMCR Institute Escondido California 92025 —
Mary & Dick Allen Diabetes Center Newport Beach California 92663 —
University Clinical Investigators, Inc. Tustin California 92780 —
University of Colorado Anschutz Medical Campus Aurora Colorado 80045 —
Metabolic Research Institute, Inc. West Palm Beach Florida 33401 —
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50266 —
HealthPartners Institute dba International Diabetes Center Minneapolis Minnesota 55416 —
Clinical Research Professionals Chesterfield Missouri 63005 —
Clinvest Headlands Llc Springfield Missouri 65807 —
Las Vegas Endocrinology Henderson Nevada 89074 —
University of North Carolina Medical Center Chapel Hill North Carolina 27514 —
Velocity Clinical Research, Dallas Dallas Texas 75230 —
Juno Research Houston Texas 77040 —
Southern Endocrinology Associates Mesquite Texas 75149 —
Texas Diabetes & Endocrinology, P.A. Round Rock Texas 78681 —
San Antonio Clinical Trials San Antonio Texas 78240 —
Texas Valley Clinical Research Weslaco Texas 78596 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 61 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06962280, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 17, 2026 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06962280 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →